Viewpoints in Retina

New Data on RTH258 Show Promise A recent phase 1/2 trial shows that RTH258 is a promising alternative to ranibizumab for the treatment of neovascular age-related macular degeneration.
Experts And Viewpoints, August 24, 2016
Cataract Surgery Has No Clear Link to AMD Study authors believe that recent advances may have eliminated earlier risks, but others caution that longitudinal data are needed to confirm this theory.
Experts And Viewpoints, July 22, 2016
Does Anti-VEGF Therapy Affect Cataract Surgery Complications? Is the cataract surgery complication rate higher in patients receiving anti-VEGF injections? Dr Sophie Bakri comments on this study from Ophthalmology.
Experts And Viewpoints, May 31, 2016
Is Cataract Surgery Safe for Patients With Wet AMD? Does cataract surgery contribute to the progression of wet age-related macular degeneration?
Experts And Viewpoints, January 19, 2016
Anti-VEGF Therapy: Data on MI, Stroke, and Mortality Risk New research evaluates whether intravitreal anti-VEGF therapy increases the risk for thromboembolic events.
Experts And Viewpoints, October 23, 2015
Updated Guidelines Issued for Intravitreal Injections An expert panel offers their thoughts on the best techniques and monitoring strategies from pre- to post-injection.
Experts And Viewpoints, June 26, 2015
Aflibercept Superior to Photocoagulation for Macular Edema? A 24-week study compares the VEGF inhibitor against macular grid laser photocoagulation used at baseline to gauge which offers superior vision improvements.
Experts And Viewpoints, March 05, 2015
Are Treat-and-Extend Protocols Effective in AMD? A 2-year analysis of treat-and-extend protocols provides important information on anti-VEGF therapy in AMD, building on earlier pivotal trials.
Experts And Viewpoints, February 02, 2015
Does Ocular Surface Prep Promote Antibiotic Resistance? A study seeks to determine whether repeated use of povidone-iodine for the prevention of endophthalmitis can have negative microbial consequences.
Experts And Viewpoints, January 07, 2015
Reticular Pseudodrusen and AMD This finding confers increased risk for AMD progression to the fellow eye.
Experts And Viewpoints, December 26, 2014
Safe to Just Observe Mild Vitreomacular Adhesion? A study looks at the outcomes of patients with vitreomacular adhesion who are managed with observation.
Experts And Viewpoints, October 16, 2014
Risk Factors for Geographic Atrophy in the CATT Trial The CATT results are discussed -- will they help ophthalmologists choose either bevacizumab or ranibizumab?
Experts And Viewpoints, September 19, 2014
Ranibizumab vs Laser in Diabetic Macular Edema Are the differences significant enough to subject patients to the high injection burden required for anti-VEGF treatment?
Experts And Viewpoints, August 06, 2014
Classifying Vitreomacular Disease A classification system that defines the features of vitreomacular adhesion, vitreomacular traction, and macular holes is useful for diagnosis and research.
Experts And Viewpoints, June 30, 2014
Long-term Outcomes of Intravitreal Injections for AMD Sadly, good 2-year results don't always translate into good long-term results.
Experts And Viewpoints, June 06, 2014
Do Omega-3 Fatty Acids Help Prevent AMD? The findings of the AREDS2 study are reviewed here. What should ophthalmologists recommend now?
Experts And Viewpoints, January 16, 2014
Ranibizumab for AMD: Dose and Frequency The HARBOR study compared the efficacy and safety of 2 doses and 2 injection frequencies in patients with age-related macular degeneration.
Experts And Viewpoints, December 17, 2013
CMV Retinitis and Cataracts in AIDS A high incidence of cataracts in patients with CMV retinitis suggests that this could be a significant source of vision loss in patients with AIDS.
Experts And Viewpoints, October 25, 2013
Statins and the Hazard of Developing AMD The clinical implications of these findings are not yet known.
Experts And Viewpoints, September 30, 2013
Visual Function After Macular Hole Surgery A study evaluates retinal microstructure and visual function after macular hole surgery using brilliant blue G vs indocyanine green to make the internal limiting membrane more visible.
Experts And Viewpoints, June 14, 2013

No Results